{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:48:17Z","timestamp":1791748097147,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["22JCZDJC0030"],"award-info":[{"award-number":["22JCZDJC0030"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2024MS059"],"award-info":[{"award-number":["TJWJ2024MS059"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2024ZD012"],"award-info":[{"award-number":["TJWJ2024ZD012"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2024RC014"],"award-info":[{"award-number":["TJWJ2024RC014"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2026ZD013"],"award-info":[{"award-number":["TJWJ2026ZD013"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012580","name":"Natural Science Foundation of Tianjin Science and Technology Correspondent Project","doi-asserted-by":"publisher","award":["25JCYBJC01780"],"award-info":[{"award-number":["25JCYBJC01780"]}],"id":[{"id":"10.13039\/501100012580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015406","name":"Tianjin Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189734","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:36:20Z","timestamp":1791318980000},"page":"189734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From recognition to serial killing: Molecular mechanisms controlling NK-cell-mediated tumor elimination"],"prefix":"10.1016","volume":"1881","author":[{"given":"Zhaojun","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueren","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189734_bb0005","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.apcsb.2022.02.001","article-title":"Natural killer cell-based strategies for immunotherapy of cancer","volume":"129","author":"Van\u011bk","year":"2022","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-0716-2160-8_19","article-title":"CRISPR screen to identify factors that render tumor cells sensitive or resistant to killing by NK cells","volume":"2463","author":"Zhuang","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2011.06.001","article-title":"Unifying concepts of MHC-dependent natural killer cell education","volume":"32","author":"Elliott","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0030","first-page":"106","article-title":"CRISPR enabled precision oncology: from gene editing to tumor microenvironment remodeling","volume":"2","author":"Li","year":"2025","journal-title":"Med. Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01851","article-title":"A flow cytometry-based whole blood natural killer cell cytotoxicity assay using overnight cytokine activation","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-8885-3_7","article-title":"CD107a degranulation assay to evaluate immune cell antitumor activity","volume":"1884","author":"Lorenzo-Herrero","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/0109298665348639250115113650","article-title":"iRGD tumor penetrating peptide-modified NK cells exhibit enhanced tumor immune infiltration ability and anti-tumor efficacy","volume":"32","author":"Song","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbcan.2026.189734_bb0050","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.103085","article-title":"A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma","volume":"99","author":"Korde","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2026.189734_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1950264","article-title":"Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors","volume":"13","author":"Wingert","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/j.bbcan.2026.189734_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coi.2018.02.004","article-title":"NKG2D and its ligands in cancer","volume":"51","author":"Dhar","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0065","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3389\/fimmu.2018.02040","article-title":"NKG2D ligands-critical targets for cancer immune escape and therapy","volume":"9","author":"Schmiedel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0070","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189734_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00508","article-title":"The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells","volume":"4","author":"Cerboni","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0080","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","article-title":"Tumor-associated MICA is shed by ADAM proteases","volume":"68","author":"Waldhauer","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","article-title":"Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes","volume":"70","author":"Ashiru","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-021-02068-5","article-title":"Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy","volume":"40","author":"Wu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0095","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00262-009-0682-y","article-title":"Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines","volume":"58","author":"Casado","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189734_bb0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/intimm\/dxab085","article-title":"DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses","volume":"33","author":"Shibuya","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/intimm\/13.2.193","article-title":"HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition","volume":"13","author":"Riteau","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0115","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI0215564","article-title":"IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94\/NKG2A-dependent mechanism","volume":"110","author":"Malmberg","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189734_bb0120","first-page":"2153","article-title":"Association of HLA class I and class II antigen expression and mortality in uveal melanoma","volume":"42","author":"Ericsson","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbcan.2026.189734_bb0125","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/1078-0432.CCR-19-2095","article-title":"The NKG2A-HLA-E Axis as a novel checkpoint in the tumor microenvironment","volume":"26","author":"Borst","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10121993","article-title":"Disruption of the NKG2A:HLA-E immune checkpoint axis to enhance NK cell activation against cancer","volume":"10","author":"Fisher","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.bbcan.2026.189734_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/ITT.S61498","article-title":"Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors","volume":"4","author":"Thomas","year":"2015","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.bbcan.2026.189734_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174131","article-title":"Hepatic tumor microenvironments and effects on NK cell phenotype and function","volume":"20","author":"Pi\u00f1eiro Fern\u00e1ndez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189734_bb0150","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3724\/j.pibb.2025.0317","article-title":"Regulatory effects of oncogenes and tumor suppressor genes on tumor immune microenvironment","volume":"52","author":"Tan","year":"2025","journal-title":"Prog. Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2026.189734_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040893","article-title":"Mechanisms of resistance to NK cell immunotherapy","volume":"12","author":"Sordo-Bahamonde","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189734_bb0160","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","article-title":"A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling","volume":"30","author":"Qian","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-0-387-72005-0_23","article-title":"The lytic NK cell immunological synapse and sequential steps in its formation","volume":"601","author":"Orange","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/imr.12107","article-title":"The central role of the cytoskeleton in mechanisms and functions of the NK cell immune synapse","volume":"256","author":"Lagrue","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189734_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.0105-2896.2010.00904.x","article-title":"Cytotoxic immunological synapses","volume":"235","author":"Dustin","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189734_bb0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10875-010-9372-y","article-title":"Navigating barriers: the challenge of directed secretion at the natural killer cell lytic immunological synapse","volume":"30","author":"Sanborn","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00390","article-title":"Activation of lymphocyte cytolytic machinery: where are we?","volume":"4","author":"Galandrini","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0190","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.4049\/jimmunol.1000761","article-title":"Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization","volume":"185","author":"Gross","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008155","article-title":"CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation","volume":"12","author":"Eitler","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189734_bb0200","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/2326-6066.CIR-24-0919","article-title":"TIGIT affects CAR NK-cell effector function in the solid tumor microenvironment by modulating immune synapse strength","volume":"13","author":"Navin","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.619069","article-title":"Intrinsic resistance of chronic lymphocytic leukemia cells to NK cell-mediated lysis can be overcome in vitro by pharmacological inhibition of Cdc42-induced actin cytoskeleton remodeling","volume":"12","author":"Wurzer","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2503259122","article-title":"Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse","volume":"122","author":"Hoffmann","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189734_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nchembio.1388","article-title":"Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion","volume":"10","author":"Hudak","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311505","article-title":"Collagen mineralization decreases NK cell-mediated cytotoxicity of breast cancer cells via increased glycocalyx thickness","volume":"36","author":"Park","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbcan.2026.189734_bb0225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/cimm.1997.1085","article-title":"A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells","volume":"176","author":"Zhang","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0230","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13046-023-02840-9","article-title":"A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity","volume":"42","author":"Lee","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41563-024-01808-0","article-title":"Immunoengineering can overcome the glycocalyx Armour of cancer cells","volume":"23","author":"Park","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbcan.2026.189734_bb0240","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1186\/s12885-025-15108-6","article-title":"Podocalyxin protects high grade serous ovarian cancer spheroids from NK cell infiltration and spheroid destruction","volume":"25","author":"Tran","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189734_bb0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2015.06.029","article-title":"Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells","volume":"368","author":"Amo","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189734_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00245","article-title":"Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1","volume":"4","author":"Amo","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350693","article-title":"PIEZO1-mediated mechanosensing governs NK-cell killing efficiency and infiltration in three-dimensional matrices","volume":"54","author":"Yanamandra","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acsbiomaterials.0c01121","article-title":"Mechanical regulation of the cytotoxic activity of natural killer cells","volume":"7","author":"Mordechay","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bbcan.2026.189734_bb0265","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/imm.12921","article-title":"Natural killer cell cytotoxicity and its regulation by inhibitory receptors","volume":"154","author":"Kumar","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.bbcan.2026.189734_bb0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imr.12014","article-title":"Building tolerance by dismantling synapses: inhibitory receptor signaling in natural killer cells","volume":"251","author":"Huse","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189734_bb0275","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.240424","article-title":"Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function","volume":"133","author":"Phatarpekar","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2026.189734_bb0280","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0952-7915(03)00113-4","article-title":"Lytic granules, secretory lysosomes and disease","volume":"15","author":"Clark","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0285","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1074\/jbc.M410915200","article-title":"Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte\/natural killer (CTL\/NK) protease granzyme B","volume":"280","author":"Adrain","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189734_bb0290","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200210158","article-title":"Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis","volume":"160","author":"Metkar","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0295","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1084\/jem.188.12.2375","article-title":"Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells","volume":"188","author":"Zamai","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189734_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbcan.2026.189734_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.117007","article-title":"ESCRT-mediated membrane remodeling in cancer immune evasion and resistance to immunotherapy: mechanisms, therapeutic vulnerabilities, and translational implications","volume":"185","author":"Wang","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0310","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41467-022-29469-0","article-title":"CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity","volume":"13","author":"Bernareggi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189734_bb0315","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8141","article-title":"Overview of serpin B9 and its roles in cancer (review)","volume":"46","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189734_bb0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lungcan.2012.01.017","article-title":"Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?","volume":"77","author":"Soriano","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189734_bb0325","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2139074","article-title":"SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response","volume":"11","author":"Ib\u00e1\u00f1ez-Molero","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189734_bb0330","article-title":"The biological function of Serpinb9 and Serpinb9-based therapy","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103726","article-title":"Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer","volume":"21","author":"Sordo-Bahamonde","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189734_bb0340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drup.2004.11.002","article-title":"Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy","volume":"7","author":"Van Geelen","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189734_bb0345","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1074\/jbc.M410985200","article-title":"A central role for bid in granzyme B-induced apoptosis","volume":"280","author":"Waterhouse","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189734_bb0350","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1074\/jbc.M008444200","article-title":"Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition","volume":"276","author":"Alimonti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189734_bb0355","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1074\/jbc.M009038200","article-title":"Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway","volume":"276","author":"Pinkoski","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189734_bb0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbcan.2026.189734_bb0365","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180002","article-title":"Targeting BCL-2 regulated apoptosis in cancer","volume":"8","author":"Campbell","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.acr.2017.11.001","article-title":"Bcl-2 Antiapoptotic family proteins and chemoresistance in cancer","volume":"137","author":"Maji","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0375","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","article-title":"Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis","volume":"185","author":"Pan","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189734_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200207","article-title":"Single-cell profiling reveals functional heterogeneity and serial killing in human peripheral and ex vivo-generated CD34+ progenitor-derived natural killer cells","volume":"7","author":"Subedi","year":"2023","journal-title":"Adv. Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0385","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20181454","article-title":"NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing","volume":"216","author":"Prager","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189734_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115156","article-title":"The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicity","volume":"44","author":"Pedroza","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189734_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.871106","article-title":"Locked and loaded: mechanisms regulating natural killer cell lytic granule biogenesis and release","volume":"13","author":"Ham","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1177670","article-title":"Lytic granule exocytosis at immune synapses: lessons from neuronal synapses","volume":"14","author":"Chang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0405","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41467-019-08384-x","article-title":"Remodeling of secretory lysosomes during education tunes functional potential in NK cells","volume":"10","author":"Goodridge","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189734_bb0410","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2015-03-632273","article-title":"Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells","volume":"126","author":"Vrazo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2026.189734_bb0415","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.20140964","article-title":"Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time","volume":"212","author":"Jenkins","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189734_bb0420","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41423-019-0277-2","article-title":"NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production","volume":"17","author":"Anft","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0425","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1083\/jcb.201712085","article-title":"Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells","volume":"217","author":"Srpan","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0430","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05033-w","article-title":"Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy","volume":"22","author":"Miao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189734_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02517","article-title":"Tumor microenvironment-induced immunometabolic reprogramming of natural killer cells","volume":"9","author":"Chambers","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303605","article-title":"NK cell exhaustion in the tumor microenvironment","volume":"14","author":"Jia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0445","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41392-020-00348-8","article-title":"Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy","volume":"5","author":"Cao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189734_bb0450","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ijc.34389","article-title":"The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity","volume":"152","author":"Tumino","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189734_bb0455","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1038\/s41467-024-54355-2","article-title":"C\/EBP\u03b2-dependent autophagy inhibition hinders NK cell function in cancer","volume":"15","author":"Portale","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189734_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101425","article-title":"Measuring trogocytosis between ovarian tumor and natural killer cells","volume":"3","author":"Delgado-Gonzalez","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.bbcan.2026.189734_bb0465","doi-asserted-by":"crossref","first-page":"9421","DOI":"10.1073\/pnas.1300140110","article-title":"Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand","volume":"110","author":"Nakamura","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189734_bb0470","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mdb2.70018","article-title":"Beyond PD-1\/PD-L1: new immune checkpoints and therapeutic combinations in cancer immunotherapy","volume":"2","author":"Li","year":"2026","journal-title":"Med. Bull."},{"key":"10.1016\/j.bbcan.2026.189734_bb0475","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/1078-0432.CCR-16-1108","article-title":"Checkpoint inhibition of KIR2D with the monoclonal antibody IPH2101 induces contraction and Hyporesponsiveness of NK cells in patients with myeloma","volume":"22","author":"Carlsten","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0480","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1078-0432.CCR-24-1991","article-title":"First-in-human phase I study of a CD16A bispecific innate cell engager, AFM24, targeting EGFR-expressing solid tumors","volume":"31","author":"El-Khoueiry","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0485","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.2009.25.4847","article-title":"Phase 1b study of dulanermin (recombinant human Apo2L\/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer","volume":"28","author":"Soria","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0490","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10637-017-0536-y","article-title":"Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand\/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer","volume":"36","author":"Ouyang","year":"2018","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbcan.2026.189734_bb0495","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1158\/1078-0432.CCR-18-3468","article-title":"IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion","volume":"25","author":"Conlon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0500","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002193","article-title":"Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies","volume":"9","author":"Dubois","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189734_bb0505","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood.V130.Suppl_1.889.889","article-title":"Randomized phase 2 trial of Lirilumab (anti-KIR monoclonal antibody, mAb) as maintenance treatment in elderly patients (pts) with acute myeloid leukemia (AML): results of the Effikir trial","volume":"130","author":"Vey","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2026.189734_bb0510","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/1078-0432.CCR-25-0073","article-title":"INTERLINK-1: a phase III, randomized, placebo-controlled study of Monalizumab plus Cetuximab in recurrent\/metastatic head and neck squamous cell carcinoma","volume":"31","author":"Fayette","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0515","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood-2011-06-360552","article-title":"A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma","volume":"120","author":"Zonder","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2026.189734_bb0520","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1470-2045(21)00342-9","article-title":"Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN ovarian 100): an open-label, randomised, phase 3 trial","volume":"22","author":"Monk","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0525","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1470-2045(21)00216-3","article-title":"Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN ovarian 200): an open-label, three-arm, randomised, phase 3 study","volume":"22","author":"Pujade-Lauraine","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0530","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189734_bb0535","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14653240802301872","article-title":"Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial","volume":"10","author":"Arai","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbcan.2026.189734_bb0540","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1200\/JCO.23.00172","article-title":"Bempegaldesleukin plus Nivolumab in untreated advanced melanoma: the open-label, phase III PIVOT IO 001 trial results","volume":"41","author":"Diab","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189734_bb0545","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/10428194.2022.2095623","article-title":"AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial","volume":"63","author":"Sasse","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbcan.2026.189734_bb0550","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41591-025-03640-8","article-title":"Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial","volume":"31","author":"Nieto","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189734_bb0555","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(24)02462-0","article-title":"Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial","volume":"405","author":"Ghobadi","year":"2025","journal-title":"Lancet"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26002064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26002064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:27:23Z","timestamp":1791746843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26002064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26002064"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189734","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From recognition to serial killing: Molecular mechanisms controlling NK-cell-mediated tumor elimination","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189734"}}